Young Richard A
SEC insider (Form 3/4/5 filer). CIK 0001490283. Director at Camp4 Therapeutics Corp (CAMP) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Aug 3, 2026. Located in CAMBRIDGE, MA.
Companies Young Richard A has filed insider reports for
- Camp4 Therapeutics Corp (CAMP): Director
- Syros Pharmaceuticals, Inc. (SYRS): Director
Young Richard A
CIK: 0001490283
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Aug 3, 2026CAMP
Camp4 Therapeutics Corp
PurchaseDirect16.4K shares at avg. $1.65$27K - Jun 10, 2026CAMP
Camp4 Therapeutics Corp
AwardDirectStock Option (Right to Buy)
28K shares- - Sep 11, 2025CAMP
Camp4 Therapeutics Corp
PurchaseDirect15.2K shares at avg. $1.65$25K - Jun 25, 2025CAMP
Camp4 Therapeutics Corp
AwardDirectStock Option (Right to Buy)
9K shares- - Oct 15, 2024CAMP
Camp4 Therapeutics Corp
ConversionDirect8.9K shares- - Sep 16, 2024SYRS
Syros Pharmaceuticals, Inc.
ExerciseDirect2.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 3, 2026 |  CAMP Camp4 Therapeutics Corp | Purchase | 16,378 | $1.65 | $27,024 | Direct |
| Jun 10, 2026 | CAMP Camp4 Therapeutics Corp | Award Stock Option (Right to Buy) | 28,000 | - | - | Direct |
| Sep 11, 2025 | CAMP Camp4 Therapeutics Corp | Purchase | 15,151 | $1.65 | $24,999 | Direct |
| Jun 25, 2025 | CAMP Camp4 Therapeutics Corp | Award Stock Option (Right to Buy) | 9,000 | - | - | Direct |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | Conversion | 8,917 | - | $0 | Direct |
| Sep 16, 2024 |  SYRS Syros Pharmaceuticals, Inc. | Exercise | 2,667 | - | $0 | Direct |
1-6 of 6 transactions